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A previously uncharacterized glutathione (GSH) transferase which is not apparent in normal liver, accounts 
for at least 25% of the soluble GSH transferase content of primary hepatomas induced by feeding N,N- 
dimethykl-aminoazobenzene. This enzyme is readily isolated, has an isoelectric point of 6.8, is composed 
of two identical subunits of apparent A4, 26000 and has GSH transferase activity towards a number of 
substrates including benzo(a)pyrene-7,8-diol-9,10-oxide. It is unusual in that it has GSH peroxidase activity 
towards fatty acid hydroperoxides but not towards the model substrates, cumene hydroperoxide and t-butyl 
hydroperoxide. It has been shown by tryptic peptide analysis to be distinct from GSH transferases com- 
posed of subunits 1,2, 3,4 or 6 and has been designated GSH transferase 7-7. 
GSH transferase 7-7 GSH peroxidase Hepatoma Purification 
1. INTRODUCTION 
An early macroscopic event in experimental 
chemical hepatocarcinogenesis is the formation of 
hyperplastic nodules and although most of these 
nodules subsequently revert to apparently normal 
hepatic tissue some persist and proceed to hepato- 
carcinomas. Farber and his. colleagues have shown 
that a variety of carcinogenic regimens give rise to 
nodules with similar phenotypic characteristics 
many of which they have pointed out are sug- 
gestive of adaptation to a toxic environment 
(reviewed in [l]). For example, marked decreases 
in the enzymes which produce electrophiles uch as 
mixed function oxygenases are combined with in- 
creases in factors involved in the detoxication of 
electrophiles and the excretion of xenobiotics such 
as GSH, GSH transferases, y-glutamyl transpep- 
tidase, NAD(P)H-quinone reductase, microsomal 
epoxide hydrolase and UDP-glucuronyl transfer- 
ase [2]. 
The glutathione (GSH) transferases are our par- 
ticular interest. They are a family of dimeric isoen- 
zymes existing as homodimers and heterodimers 
with a distribution which is specific to a tissue and 
perhaps relevant o its function [3]. Here, we have 
examined a series of hepatomas brought about by 
feeding N,N-dimethyl-aminoazobenzene (DAB) 
and isolated and characterized a GSH transferase 
abundant in all these hepatomas, present in several 
normal tissues examined, but not evident in nor- 
mal liver. It has been agreed by the consulting 
group for the nomenclature of GSH transferases 
[4] it should be called GSH transferase 7-7. 
2. MATERIALS AND METHODS 
2.1. Induction of hepatomas by N,N-dimethyl- 
Caminoazobenzene (DAB) 
Tumour-bearing rats were kindly provided by 
Dr J. Embleton, Cancer Research Campaign 
Laboratories, University of Nottingham. They 
were male Wistar rats, initially weighing 100 g, 
which were fed a powdered diet containing 0.06% 
DAB, 0.2% corn oil, 9.8% dried carrot and 88.2% 
unpolished rice for 3 months, then transferred to 
a standard laboratory diet until hepatomas were 
judged to be present (in the region of 8 months). 
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The rats were then killed, hepatomas were dissect- 
ed free of surrounding tissue, frozen in liquid 
nitrogen and stored at - 70°C prior to use. 
2.2. Enzyme assays 
GSH transferase, GSH peroxidase and A’-3- 
keto-steroid isomerase activities towards model 
substrates were determined according to [5]. GSH 
transferase activity towards the carcinogens N- sul- 
phonyloxy-N-acetyl-2aminofluorene, N-acetoxy- 
N-acetyl-2-aminofluorene (prepared according to 
[6]) and benzo(a)pyrene-7,8-diol-9,10-oxide (sup- 
plied by Dr Bengt Jernstrom, Karolinska Insti- 
tutet, Stockholm) was determined by measuring 
respective GSH conjugates separated by HPLC 
[7]. Hydroperoxides of the naturally occurring 
linoleic and arachidonic acids prepared as de- 
scribed by O’Brien [8] were used as GSH perox- 
idase substrates. 
2.3. Separation of GSH transferases 
Hepatoma tissues were thawed, minced and 
homogenised in two volumes of buffer containing 
0.2 M sucrose, 2 mM EDTA, 0.5 mM PMSF, 
10 mM KHzp0.1 and 15 mM Tris base adjusted to 
pH 7.8 with KOH and the soluble supernatant 
fraction obtained by centrifugation at 105000 x g 
for 1 h. The GSH transferase fraction was separat- 
ed by use of the affinity matrix S-hexylglutathione- 
Sepharose and from it GSH transferase 7-7 was 
purified by adsorption onto a column of hydroxy- 
apatite (1 x 20 cm) in 7 mM sodium phosphate, 
1 mM EDTA (pH 6.5) and elution with a gradient 
of potassium phosphate. Fractions containing 
GSH transferase 7-7 were eluted at approx. 20 mM 
potassium phosphate, and were pooled and re- 
chromatographed on hydroxyapatite to yield a 
homogenous protein. Glutathione transferase 7-7 
was isolated in a similar fashion from kidney, 
skeletal muscle, testis and epididymis. The purity 
of the GSH transferase 7-7 preparation was as- 
sessed by SDS-PAGE (polyacrylamide gel electro- 
phoresis) and isoelectric focusing on a sucrose den- 
sity gradient. 
A comparison of the soluble GSH transferases 
obtained in hepatoma with those in normal liver 
was made by subjecting eluates from S-hexylglu- 
tathione-Sepharose affinity columns to isoelectric 
focusing. 
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2.4. Protein analysis 
The amino acid content of GSH transferase 7-7 
was determined by Dr A. Aitken, School of Phar- 
macy, University of London and tryptic peptide 
maps were prepared as previously described [5]. 
2.5. Immunology 
Antisera to GSH transferase 7-7 were raised in 
mice and tested by standard radioimmunoassay 
procedures using 1Z51-labelled sheep anti-mouse 
F(Ab’)z provided by Dr D. Male, Dept. of Im- 
munology, Middlesex Hospital Medical School, 
London. 
3. RESULTS 
3.1. Purification and characterisation of GSH 
transferase 7- 7 
GSH transferase 7-7 was readily purified by 
chromatography on hydroxyapatite since it was 
desorbed at much lower phosphate concentration 
than other GSH transferases (fig.1). It gave a ma- 
jor peak at pZ 6.8 on isoelectric focusing and a 
single band on SDS-PAGE migrating faster than 
subunit 1 and with an apparent Mr of 26000. Its 
amino acid content shown in table 1 is unusual 
among GSH transferase so far studied for its very 
Fraction Number (4ml) 
Fig.1. Purification of GSH transferase 7-7. The GSH 
transferase fraction obtained by affinity chromatogra- 
phy from a 15 g DAB-induced hepatoma was applied to 
a column of hydroxyapatite as described in section 2. 
GSH transferase activity towards I-chloro-2,4-dinitro- 
benzene (CDNB) is given in pmol/min per ml. Fractions 
25-28 were re-chromatographed to yield an apparently 
pure enzyme. 
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Table 1 
The amino acid composition of GSH transferases l-l, 
2-2, 3-3, 4-4 and 7-7 
Amino acid GSH transferase= 
l-l 2-2 3-3 4-4 7-7 
Asx 10.1 10.3 11.1 11.0 12.3 
Thr 3.5 3.2 3.0 3.5 3.5 
Ser 4.4 4.1 4.6 5.1 4.9 
Glx 11.7 11.7 11.6 11.5 10.9 
Pro 4.9 4.5 6.0 6.4 4.8 
Gly 5.4 5.6 4.8 5.9 9.6 
Ala 7.5 7.6 5.2 5.8 6.8 
Val 4.7 4.9 2.2 3.1 6.2 
CYS 0.9 0.9 1.1 0.9 2.1 
Met 3.8 3.6 3.6 2.8 <0.3 
Ile 4.5 5.0 5.5 4.3 3.6 
Leu 13.0 12.6 11.5 10.7 14.1 
Tyr 3.5 3.7 6.6 5.6 3.6 
Phe 4.5 4.2 5.8 6.2 3.1 
His 1.4 1.5 1.7 2.3 3.2 
LYS 9.6 9.9 9.1 8.4 6.2 
Arg 6.1 6.3 6.2 5.4 3.4 
Trp 0.5 0.5 0.5 0.5 1.4 
a Amino acid content is expressed as mol% 
low level of methionine and relatively high level of 
glycine. The expected yield of tryptic peptides 
from subunits of a homodimer with this composi- 
tion is 26. 31 peptides are found in the tryptic pep- 
tide map shown in fig.2. This value is in sufficient 
agreement with the amino acid analysis to indicate 
that the subunits in GSH transferase 7-7 are iden- 
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Fig.2. Tryptic peptides of GSH transferase 7-7. Purified 
GSH transferase 7-7 was compared in this example with 
GSH transferase 3-3 by thin layer tryptic peptide 
mapping as described in [5]. 
Comparison of the tryptic peptide map for GSH 
transferase 7-7 with those of GSH transferases l-l, 
2-2, 3-3 (see fig.2), 4-4 or 6-6 suggested much less 
homology between subunit 7 and subunits 1, 2, 3, 
4 or 6 than has been shown to exist [S] between 
subunits 1 and 2 on the one hand and subunits 3, 
4 and 6 on the other. Also antibody raised to GSH 
transferase 7-7 gave very low titres with GSH 
transferases l-2 and 3-4. 
3.2. Enzymic properties and tissue distribution of 
GSH transferase 7-7 
Enzymic activities of GSH transferase 7-7 are 
shown in table 2. It has one characteristic which is 
unique so far, namely while it has GSH peroxidase 
activity towards fatty acid hydroperoxide it is 
almost inactive with the usual model organic 
substrates for GSH peroxidase activity, cumene 
hydroperoxide and t-butyl hydroperoxide. This is 
its main distinguishing characteristic, but high ac- 
tivity towards ethacrynic acid is also noteworthy. 
Otherwise it utilizes 1 -chloro-2,4_dinitrobenzene as 
a substrate like most other GSH transferases but is 
inactive towards A5-androstene-3,17-dione, cu- 
mene hydroperoxide, 1,2-dichloro-4nitrobenzene 
and trans-4-phenyl-3-buten-2-one which are sub- 
strates used to identify subunits 1, 2, 3, 4 respec- 
tively. It has appreciable activity towards 1,2-ep- 
oxy-3-@-nitrophenoxy)propane but substantially’ 
less than that of GSH transferase 5-5. Highly reac- 
tive carcinogen metabolites have also been tested. 
Like all GSH transferases tested so far it is active 
towards benzo(a)pyrene-7,8-diol-9,10-oxide [7,9] 
and inactive towards N-sulphonyloxy-N-acetyl-2- 
aminofluorene or its analogue N-acetoxy-N-acetyl- 
2-aminofluorene [9]. 
Among tissues which were examined, namely 
primary hepatoma, normal liver, kidney, skeletal 
muscle, testis and epididymis, GSH transferase 7-7 
was a major component of hepatoma, kidney and 
skeletal muscle, present in testis and epididymis, 
but not evident in liver. 
In the hepatoma GSH transferase 7-7 accounted 
for about 25% of the total GSH transferase pro- 
tein and the content of GSH transferase 3-3 was 
almost twice its level in normal liver (fig.3). The 
levels of GSH transferases l-l, 1-2 and 2-2 were 
reduced to varying extents in the hepatomas com- 
pared to normal liver. Other isoenzymes were at 
similar levels in both tissues. Similar patterns of 
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Table 2 
Activity of GSH transferase homodimers to a range of substrates 
l-l 2-2 3-3 4-4 5-5 6-6 7-7 
1-Chloro-2,4-dinitrobenzene 34 32 44 16 tr. 187 20 
1,2-Dichloro-4-nitrobenzene 0.15 0.15 8.4 0.7 nil 0.26 nil 
trans-4-Phenyl-3-buten-2-one 0.1 0.1 0.1 1.2 nil 0.1 0.02 
p-Nitro-phenethyl bromide nd nd 0.1 nd 4.2 nd nil 
1,2-Epoxy-3-@-nitrophenoxy)propane 0.7 0.9 0.2 0.9 25.5 0.1 1.0 
Ethacrynic acid 0.3 2.1 0.4 1.0 nil 0.1 4.0 
Cholesterol cr-epoxidea 0.14 0.14 nil nil nil nd nd 
Benzo(a)pyrene-7,8-diol-9,10-epoxide 0.10 0.08 0.03 0.36 nil 0.19 0.33 
N-Sulphonyloxy-N-acetyl-2-aminofluorene nil nil nil nil nil nil nil 
Cumene hydroperoxides 1.4 3.0 0.1 0.4 12.5 0.04 0.01 
t-Butyl hydroperoxide 0.1 0.5 0.04 0.1 nd nd 0.02 
Linoleate hydroperoxides 3.0 1.6 0.2 0.2 nd 0.06 1.5 
Arachidonate hydroperoxides 2.6 1.7 0.2 0.2 nd 
AS-Androstene-3,17-dione 
nd 1.5 
0.23 0.07 nd nd nd nd <O.OOl 
Activities are expressed as pmol/min per mg protein or a nmol/min per mg protein. nd, not determined; tr., trace 
Fraction Number (am 
) 
PH 
Fig.3. Comparison of the GSH transferase content of 
primary hepatoma with that of normal liver. The GSH 
transferase fractions were purified by affinity chro- 
matography, subjected to isoelectric focusing in a 
sucrose gradient [5] and identified by assaying activity 
with a range of substrates combined with electrophoretic 
analysis of subunit composition as described in section 
2. GSH transferase activity from a 3.5 g hepatoma 
(-) is compared with that from 3.5 g of normal liver 
(---). 
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GSH transferase were obtained with primary 
hepatomas ranging in weight from 0.5 to 20 g. 
4. DISCUSSION 
This paper describes a GSH transferase which 
accounts for 25% of the total GSH transferase of 
hepatoma and is also present in kidney, skeletal 
muscle, testis and epididymis, kidney being the 
richest source of this enzyme so far among normal 
tissues. Mannervik et al. (personal communica- 
tion) have also isolated an enzyme from kidney 
which appears to be identical to the enzyme 
described here. By reference to Jakoby et al. [4] the 
enzyme has been named GSH transferase 7-7. This 
enzyme is probably identical to a GSH transferase 
isolated from hyperplastic hepatic nodules, placen- 
ta, kidney and lung by Sato et al. [lo, 1 l] and refer- 
red to as GST (P). It is also most probably iden- 
tical to the marker protein for preneoplasia, ~21, 
first seen by Eriksson et al. [12] and the ~26-6.8 
protein seen in both preneoplastic nodules and 
primary hepatoma by Sugioka et al. [ 131. 
GSH transferase 7-7 utilizes a wide range of 
substrates including the ultimate carcinogen ben- 
zo(a)pyrene-7,8-diol-oxide. It is unique so far in 
having GSH peroxidase activity for the biological- 
ly significant arachidonic and linoleic acid hydro- 
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peroxides but not the model substrates cumene 
hydroperoxide and t-butyl hydroperoxide. 
It is particularly interesting in that like other 
GSH transferases it does not catalyse the GSH 
conjugation of the electrophilic metabolite of N- 
acetyl-2-aminofluorene (AAF), N-sulphonyloxy- 
AAF, nor the synthetic analogue N-acetoxy-AAF. 
Thus, the presence of GSH transferase 7-7 is 
unlikely to contribute to the resistance to AAF tox- 
icity which characterises hyperplastic nodules [ 11. 
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